SIRT1 activates NRF2 by inhibiting p53 through deacetylation, formulating the SIRT1/p53/NRF2 pathway to regulate the pathogenesis of diabetic nephropathy [20,47]. The gene discussed is TP53; the disease is diabetic kidney disease.